In Episode 22 of the Biopharma EHS podcast, Dean M. Calhoun, CIH, President of Affygility Solutions, interviews Ms. Stephanie Wilkins, President of PharmaConsult US, regarding the topic of Risk-MaPP, ADEs and PDEs: Their importance to multi-product pharmaceutical manufacturing facilities. The interview is approximately 22-minutes long and is available on Affygility Solutions’ Facebook page, Soundcloud, iTunes, and now on Stitcher. You can also listen via the audio player below:
If you like what you heard, please share it,and if you need either an occupational exposure limit (OEL) or acceptable daily exposure (ADE) value for your active pharmaceutical ingredient, check out the OEL Fastrac catalog for a complete listing of all our occupational exposure limit monographs with ADEs (also known as PDE reports). Purchase online with immediate instant download!